Kadima, Israel

Inbal Shumacher

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Teva Pharmaceuticals International Gmbh. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inbal Shumacher. Retrieved from https://idiyas.com/inventor/inbal-shumacher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inbal Shumacher: Innovator in Pharmaceutical Chemistry

Introduction

Inbal Shumacher is a notable inventor based in Kadima, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of medications. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Inbal Shumacher's latest patents focus on solid-state forms of Belumosudil and its salts. The present disclosure encompasses solid-state forms of Belumosudil, including crystalline polymorphs of Belumosudil or salts thereof. It also details processes for the preparation of these forms and their pharmaceutical compositions. This innovation is crucial for enhancing the efficacy and stability of the medication.

Career Highlights

Throughout his career, Inbal has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Teva Pharmaceuticals International GmbH and Assia Chemical Industries Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Inbal has collaborated with several professionals in his field, including Polina Lapido and Ofir Shaul. These collaborations have likely enriched his research and development efforts, fostering a creative environment for innovation.

Conclusion

Inbal Shumacher stands out as an inventor dedicated to advancing pharmaceutical chemistry through his innovative patents. His work on solid-state forms of Belumosudil showcases his commitment to improving medication formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…